Abstract
Matrix metalloproteinases (MMPs) are implicated in joint destruction in rheumatoid arthritis (RA). We investigated whether the 5A/6A polymorphism within the MMP-3 (stromelysin-1) gene promoter region is associated with disease outcome in 254 patients with established RA. Patients homozygous for the MMP-3 6A allele had more radiographic damage (measured by Larsen score) than those with other genotypes (109.8 vs 91.1, P=0.04). Patients with the 6A/6A genotype also had more functional impairment and higher serum proMMP-3 levels, although only the latter was significant (P=0.002). A possible association was found between homozygosity for the 6A allele and carriage of the RA-associated HLA-DRB1 shared epitope (SE). Combination of these factors was associated with more severe disease than the SE alone. The data suggest that the MMP-3 6A/6A genotype is associated with worse RA outcome, and that this genotype may have an additive effect with the SE on disease severity.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 digital issues and online access to articles
$119.00 per year
only $19.83 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Docherty AJP, Murphy G . The tissue metalloproteinase family and the inhibitor TIMP: a study using cDNAs and recombinant proteins. Ann Rheum Dis 1990; 49: 469–479.
Gravallese EM, Darling JM, Ladd AL, Katz JN, Glimcher LH . In situ hybridization studies of stromelysin and collagenase messenger RNA expression in rheumatoid synovium. Arthritis Rheum 1991; 34: 1076–1084.
Walakovits L, Moore VL, Bhardwaj N, Gallick GS, Lark MW . Detection of stromelysin and collagenase in synovial fluid from patients with rheumatoid arthritis and posttraumatic knee injury. Arthritis Rheum 1992; 35: 35–42.
Nagase H . Activation mechanism of matrix metalloproteinases. Biol Chem 1997; 378: 151–160.
Cowell S, Knauper V, Stewart ML et al. Induction of matrix metalloproteinase activation cascades based on membrane type 1 matrix metalloproteinase: associated activation of gelatinase A, gelatinase B and collagenase-3. Biochem J 1998; 331: 453–458.
Taylor DJ, Cheung NT, Dawes PT . Increased serum proMMP-3 in inflammatory arthritides: a potential indicator of synovial inflammatory monokine activity. Ann Rheum Dis 1994; 53: 768–772.
Zucker S, Lysik RM, Zarrabi MH et al. Elevated plasma stromelysin levels in arthritis. J Rheumatol 1994; 21: 2329–2333.
Keyszer G, Lambiri I, Nagel R et al. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1(TIMP-1) and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers. J Rheumatol 1999; 26: 251–258.
Cheung NT, Dawes PT, Poulton KV, Ollier WER, Taylor DJ, Mattey DL . High serum levels of proMMP-3 are associated with greater radiographic damage and the presence of the shared epitope in patients with rheumatoid arthritis. J Rheumatol 2000; 27: 882–887.
Gregersen PK, Silver J, Winchester RJ . The shared epitope hypothesis: an approach to understanding the molecular genetics of susceptiblity to rheumatoid arthritis. Arthritis Rheum 1987; 30: 1205–1213.
Ye S, Watts GF, Mandalia S, Humphries SE, Henney AM . Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis. Br Heart J 1995; 73: 209–215.
Ye S, Eriksson P, Hamsten A, Kurkinen M, Humphries SE, Henney AM . Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. J Biol Chem 1996; 271: 13055–13060.
Ye S, Whatling C, Watkins H, Henney A . Human stromelysin gene promoter activity is modulated by transcription factor ZBP-89. FEBS Lett 1999; 450: 268–272.
Constantin A, Lauwers-Cances V, Naxaux F et al. Stromelysin 1 (matrix metalloproteinase 3) and HLA-DRB1 gene polymorphisms. Arthritis Rheum 2002; 46: 1754–1762.
Schwarz A, Haberbosch W, Tillmanns H, Gardemann A . The stromelysin-1 5A/6A promoter polymorphism is a disease marker for the extent of coronary heart disease. Dis Markers 2002; 18: 121–128.
van Doornum S, McColl G, Wicks IP . Accelerated atherosclerosis. An extra-articular feature of rheumatoid arthritis? Arthritis Rheum 2002; 46: 862–873.
del Rincon I, Williams K, Stern MP, Freeman GL, Escalante A . High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001; 44: 2737–2745.
Wallberg Jonsson SW, Backman C, Johnson O et al. Increased prevalence of atherosclerosis in patients with medium term rheumatoid arthritis. J Rheumatol 2001; 28: 2597–2602.
Kumeda Y, Inaba M, Goto H et al. Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis. Arthritis Rheum 2002; 46: 1489–1497.
Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–324.
Larsen A, Dale K, Eck M . Radiographic evaluation of rheumatoid arthitis and related conditions by standard reference films. Acta Radiol (Diagn Stockh) 1977; 18: 481–491.
Plant MJ, Saklatvala J, Borg AA, Jones PW, Dawes PT . Measurement and prediction of radiological progression in early rheumatoid arthritis. J Rheumatol 1994; 21: 1808–1813.
Fries JF, Spitz P, Kraines RG, Holman HR . Measurement of patient outcome in arthritis. Arthritis Rheum 1980; 23: 137–145.
Gnasso A, Motti C, Irace C et al. Genetic variation in human stromelysin gene promoter and common carotid geometry in healthy male subjects. Arterioscler Thromb Vasc Biol 2000; 20: 1600–1605.
Acknowledgements
This work was supported by the Haywood Rheumatism Research and Development Foundation and the Arthritis Research Campaign.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mattey, D., Nixon, N., Dawes, P. et al. Association of matrix metalloproteinase 3 promoter genotype with disease outcome in rheumatoid arthritis. Genes Immun 5, 147–149 (2004). https://doi.org/10.1038/sj.gene.6364050
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gene.6364050
Keywords
This article is cited by
-
Lack of association of matrix metalloproteinase-3 gene polymorphism with susceptibility to rheumatoid arthritis: a meta-analysis
BMC Musculoskeletal Disorders (2014)
-
Role of plasma matrix-metalloproteases (MMPs) and their polymorphisms (SNPs) in sepsis development and outcome in ICU patients
Scientific Reports (2014)
-
MMP expression in rheumatoid inflammation: the rs11568818 polymorphism is associated with MMP-7 expression at an extra-articular site
Genes & Immunity (2013)
-
Association of MMP-3 (-1612 5A/6A) polymorphism with knee osteoarthritis in Thai population
Rheumatology International (2013)
-
Influence of variations across the MMP-1 and -3 genes on the serum levels of MMP-1 and -3 and disease activity in rheumatoid arthritis
Genes & Immunity (2012)